India's Indoco signs on to make meds for Aspen

India's Indoco Remedies inked a deal to supply generic products to South Africa's Aspen Pharmacare for sale in the Australian market. Aspen bought Australia-based Sigma Pharmaceuticals' generics business early this year, and Indoco has started making the oral and injectable products Aspen acquired in that deal. Report 

Suggested Articles

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.

An $8 billion jury verdict against Johnson & Johnson raised eyebrows back in October, but the judge has now slashed damages to just $6.8 million.